Medical School

  • Harvard Medical School , Boston , MA


  • University of Massachusetts Medical Center , Worcester , MA


  • Massachusetts Eye and Ear Infirmary , Boston , MA


  • Boston Children's Hospital , Boston , MA

Philosophy of Care

I've been a part of the Otolaryngology department at Boston Children's Hospital for over 20 years. I work in several multi-disciplinary teams, caring for children with complex disorders involving the larynx and airway. We feel that a coordinated team approach is most helpful for patients and families, and helps achieve the best possible outcomes.


Dr. Roger Nuss is an Associate in Otolaryngology and the Director of the Pediatric Voice and Velopharyngeal Dysfunction Program at Boston Children’s Hospital. He is also an Assistant Professor of Otology and Laryngology at Harvard Medical School. He has served as an expert in an ASHA web forum on Pediatric Voice Disorders, and has published numerous papers related to vocal fold nodules and voice disorders.


  • American Board of Otolaryngology
  • American Broncho-Esophagological Association
  • American Society of Pediatric Otolaryngology
  • Society for Ear, Nose, and Throat Advances in Children (SENTAC)


Publications powered by Harvard Catalyst Profiles

  1. Barriers to Voice Therapy in Dysphonic Children. J Voice. 2021 Feb 23. View abstract
  2. International Pediatric Otolaryngology Group (IPOG) survey: Efforts to avoid complications in home tracheostomy care. Int J Pediatr Otorhinolaryngol. 2021 Feb; 141:110563. View abstract
  3. International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Management of suprastomal collapse in the pediatric population. Int J Pediatr Otorhinolaryngol. 2020 Dec; 139:110427. View abstract
  4. Patient and caregiver experiences at a Multidisciplinary Tracheostomy Clinic. Int J Pediatr Otorhinolaryngol. 2020 Oct; 137:110250. View abstract
  5. A 10-year Retrospective Review of Botulinum Toxin Injections and Surgical Management of Sialorrhea. Cureus. 2020 May 01; 12(5):e7916. View abstract
  6. Laryngeal Web in the Pediatric Population: Evaluation and Management. Otolaryngol Head Neck Surg. 2020 Feb; 162(2):234-240. View abstract
  7. Association of a Multidisciplinary Care Approach With the Quality of Care After Pediatric Tracheostomy. JAMA Otolaryngol Head Neck Surg. 2019 Nov 01; 145(11):1035-1042. View abstract
  8. Improving Tracheostomy Care in Resource-Limited Settings. Ann Otol Rhinol Laryngol. 2020 Feb; 129(2):181-190. View abstract
  9. International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations. Int J Pediatr Otorhinolaryngol. 2020 Jan; 128:109697. View abstract
  10. Preoperative augmentative and alternative communication enhancement in pediatric tracheostomy. Laryngoscope. 2020 07; 130(7):1817-1822. View abstract
  11. Vocal Pitch Discrimination in Children with and without Vocal Fold Nodules. Appl Sci (Basel). 2019 Aug; 9(15). View abstract
  12. Prevalence of voice disturbances in pediatric airway patients: Are we missing anything? Int J Pediatr Otorhinolaryngol. 2019 Mar; 118:59-61. View abstract
  13. Medialization Laryngoplasty in Pediatric Patients With Unilateral Vocal Fold Immobility: A Case Series. Ann Otol Rhinol Laryngol. 2019 Feb; 128(2):145-151. View abstract
  14. Aspiration in children with unilateral vocal fold paralysis. Laryngoscope. 2019 03; 129(3):569-573. View abstract
  15. Pediatric vincristine-related vocal fold paralysis. Int J Pediatr Otorhinolaryngol. 2018 11; 114:166-169. View abstract
  16. Voice Abnormalities and Laryngeal Pathology in Preterm Children. Ann Otol Rhinol Laryngol. 2018 Aug; 127(8):508-513. View abstract
  17. A standardized, closed-loop system for monitoring pediatric tracheostomy-related adverse events. Laryngoscope. 2018 10; 128(10):2419-2424. View abstract
  18. Nasal septal perforation in children: Presentation, etiology, and management. Int J Pediatr Otorhinolaryngol. 2017 Jan; 92:176-180. View abstract
  19. Paradoxical vocal fold motion in children presenting with exercise induced dyspnea. Int J Pediatr Otorhinolaryngol. 2016 Nov; 90:165-169. View abstract
  20. International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Routine peri-operative pediatric tracheotomy care. Int J Pediatr Otorhinolaryngol. 2016 Jul; 86:250-5. View abstract
  21. Upper Airway Anomalies in Congenital Tracheoesophageal Fistula and Esophageal Atresia Patients. Ann Otol Rhinol Laryngol. 2015 Oct; 124(10):808-13. View abstract
  22. A retrospective review of the progression of pediatric vocal fold nodules. JAMA Otolaryngol Head Neck Surg. 2014 Mar; 140(3):233-6. View abstract
  23. Validation of a pediatric vocal fold nodule rating scale based on digital video images. Ann Otol Rhinol Laryngol. 2012 Jan; 121(1):1-6. View abstract
  24. Predictors of velopharyngeal insufficiency after Le Fort I maxillary advancement in patients with cleft palate. J Oral Maxillofac Surg. 2011 Aug; 69(8):2226-32. View abstract
  25. Minimally invasive endoscopic management of subglottic stenosis in children: success and failure. Int J Pediatr Otorhinolaryngol. 2011 May; 75(5):652-6. View abstract
  26. Correlation of vocal fold nodule size in children and perceptual assessment of voice quality. Ann Otol Rhinol Laryngol. 2010 Oct; 119(10):651-5. View abstract
  27. A grading scale for pediatric vocal fold nodules. Otolaryngol Head Neck Surg. 2007 Feb; 136(2):193-7. View abstract
  28. The presentation and management of laryngeal cleft: a 10-year experience. Arch Otolaryngol Head Neck Surg. 2006 Dec; 132(12):1335-41. View abstract
  29. Perceptual voice characteristics in pediatric unilateral vocal fold paralysis. Otolaryngol Head Neck Surg. 2006 Apr; 134(4):618-21. View abstract
  30. Reliability of progressive and additive MRI scoring systems for evaluation of haemophilic arthropathy in children: expert MRI Working Group of the International Prophylaxis Study Group. Haemophilia. 2005 May; 11(3):245-53. View abstract
  31. Pediatric vocal nodules: correlation with perceptual voice analysis. Int J Pediatr Otorhinolaryngol. 2005 Jul; 69(7):903-9. View abstract
  32. The biology and management of laryngeal neurofibroma. Arch Otolaryngol Head Neck Surg. 2004 Dec; 130(12):1400-6. View abstract
  33. Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions. Haemophilia. 2004 Oct; 10 Suppl 4:88-93. View abstract
  34. The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: friend or foe? Arch Otolaryngol Head Neck Surg. 2002 Apr; 128(4):401-6. View abstract
  35. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol. 2001 Sep; 68(1):37-42. View abstract
  36. The varicella-autoantibody syndrome. Pediatr Res. 2001 Sep; 50(3):345-52. View abstract
  37. Late clinical, plain X-ray and magnetic resonance imaging findings in haemophilic joints treated with radiosynoviorthesis. Haemophilia. 2000 Nov; 6(6):658-63. View abstract
  38. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood. 2000 Jul 15; 96(2):437-42. View abstract
  39. MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia. 2000 May; 6(3):162-9. View abstract
  40. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr. 2000 Apr; 136(4):446-53. View abstract
  41. Electroglottography in the pediatric population. Arch Otolaryngol Head Neck Surg. 1999 Oct; 125(10):1105-8. View abstract
  42. Management of distal tracheal stenosis. Arch Otolaryngol Head Neck Surg. 1999 Mar; 125(3):325-8. View abstract
  43. Medical care for haemophilia. Haemophilia. 1998 Nov; 4(6):806-11. View abstract
  44. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis. Am J Hematol. 1998 Jan; 57(1):29-32. View abstract
  45. Health care provider and self-assessment of health status and sexual behaviour in HIV-seropositive young men with haemophilia. Haemophilia. 1997 Oct; 3(4):270-6. View abstract
  46. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol. 1997 Mar; 96(3):484-9. View abstract
  47. Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope. 1995 Aug; 105(8 Pt 1):801-8. View abstract
  48. Childhood thrombosis. Pediatrics. 1995 Aug; 96(2 Pt 1):291-4. View abstract
  49. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol. 1994 May; 16(2):127-31. View abstract
  50. Cardiopulmonary function in men with sickle cell trait who reside at moderately high altitude. J Lab Clin Med. 1993 Oct; 122(4):382-7. View abstract
  51. Plasma-mediated excimer laser ablation of bone: a potential microsurgical tool. Am J Otolaryngol. 1989 Mar-Apr; 10(2):76-84. View abstract
  52. Cervical human papilloma virus infection: is treatment possible? J Fla Med Assoc. 1988 Dec; 75(12):799-800. View abstract
  53. Infrared laser bone ablation. Lasers Surg Med. 1988; 8(4):381-91. View abstract
  54. Unscheduled DNA synthesis following excimer laser ablation of the cornea in vivo. Invest Ophthalmol Vis Sci. 1987 Feb; 28(2):287-94. View abstract